Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tempol Hydroxylamine SCHEMBL23902 | 0.74 | GAA (0.56) | GAAL3MBTL1 | |
| SCHEMBL76674 | 0.74 | GAA (0.39) | GAAL3MBTL1 | |
| Tempol Hydroxylamine SCHEMBL987556 | 0.72 | GAA (0.54) | GAAL3MBTL1 | |
| SCHEMBL6158821 | 0.72 | GAA (0.37) | GAAL3MBTL1 | |
| SCHEMBL17535291 | 0.72 | — | — | |
| Tempol SCHEMBL23234 | 0.72 | GAA (0.37) | GAAL3MBTL1 | |
| Water SCHEMBL11620837 | 0.72 | GAA (0.37) | GAAL3MBTL1 | |
| SCHEMBL13142113 | 0.72 | GAA (0.37) | GAAL3MBTL1 | |
| SCHEMBL7215584 | 0.72 | GAA (0.37) | GAAL3MBTL1 | |
| SCHEMBL14260011 | 0.72 | GAA (0.37) | GAAL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110200484-A1 | DISINFECTING, NONBLEACHING N-HALAMINE FOR USE WITH CONTACT LENS | AUBURN UNIVERSITY (US) | 2011-08-18 | — | — | US | claimed |
| WO-2010138852-A2 | N-HALAMINE FORMULATIONS WITH ENHANCED ANTIMICROBIAL ACTIVITY | ALCON RESEARCH, LTD. (US) | 2010-12-02 | — | — | WO | claimed |
| US-20100303930-A1 | N-HALAMINE FORMULATIONS WITH ENHANCED ANTIMICROBIAL ACTIVITY | ALCON RESEARCH, LTD. (US) | 2010-12-02 | — | — | US | claimed |
| US-20230321314-A1 | N-HALAMINE CONTAINING FIBROUS COMPOSITIONS AND USES THEREOF | UNIV AUBURN (US) | 2023-10-12 | — | — | US | disclosed |
| CN-109295524-B | Preparation method of antibacterial shape memory fiber | 四川大学 | 2021-06-08 | — | — | CN | disclosed |
| US-10981868-B1 | Single step regioselective cyclization and chlorination of hydroxyamino-N-(2-methylphenyl)acetamide to 5-chloro-7-methylindoline-2,3-dione | Tagros Chemicals India Pvt. Ltd. (IN) | 2021-04-20 | — | — | US | disclosed |
| US-20190160199-A1 | N-HALAMINE CONTAINING FIBROUS COMPOSITIONS AND USES THEREOF | AUBURN UNIVERSITY | 2019-05-30 | — | — | US | disclosed |
| US-10178866-B2 | N-halamine containing fibrous compositions and uses thereof | AUBURN UNIVERSITY (US) | 2019-01-15 | — | — | US | disclosed |
| EP-3209828-A1 | N-HALAMINE CONTAINING FIBROUS COMPOSITIONS AND USES THEREOF | Auburn University (US) | 2017-08-30 | — | — | EP | disclosed |
| US-20160106098-A1 | N-Halamine Containing Fibrous Compositions and Uses Thereof | AUBURN UNIVERSITY | 2016-04-21 | — | — | US | disclosed |
| US-8883077-B2 | Disinfecting, nonbleaching N-halamine for use with contact lens | AUBURN UNIVERSITY (US) | 2014-11-11 | — | — | US | disclosed |
| CN-101993412-A | Hindered amine compound containing bis-benzophenone structure for light stabilizer and preparation method thereof | BEIJING TIANGANG AUX Y CO LTD | 2011-03-30 | — | — | CN | disclosed |
| WO-2010138852-A2 | N-HALAMINE FORMULATIONS WITH ENHANCED ANTIMICROBIAL ACTIVITY | ALCON RESEARCH, LTD. (US) | 2010-12-02 | — | — | WO | disclosed |
| US-20100303930-A1 | N-HALAMINE FORMULATIONS WITH ENHANCED ANTIMICROBIAL ACTIVITY | ALCON RESEARCH, LTD. (US) | 2010-12-02 | — | — | US | disclosed |
| CN-101885701-A | Hindered amine compound having double-hindered phenol structure for light stabilizer and preparation method thereof | BEIJING TIANGANG AUX Y CO LTD | 2010-11-17 | — | — | CN | disclosed |
| CN-101845013-A | Multi-hindered piperidyl-containing hindered amide compound used for light stabilizer and preparation method thereof | BEIJING TIANGANG AUX Y CO LTD | 2010-09-29 | — | — | CN | disclosed |
| CN-101381477-A | Hindered amine light stabilizer and synthetic method thereof | UNIV TIANJIN (CN) | 2009-03-11 | — | — | CN | disclosed |
| US-4931562-A | Piperidines | LION CORPORATION (JP) | 1990-06-05 | — | — | US | disclosed |
| EP-0328697-A1 | Bleaching composition | LION CORPORATION (JP) | 1989-08-23 | — | — | EP | disclosed |
| US-4820437-A | MIXTURE OF HYDROGEN PEROXIDE AND NITROGEN CONTAINING HETEROCYCLIC ACTIVATORS | LION CORPORATION (JP) | 1989-04-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160106098-A1 | N-Halamine Containing Fibrous Compositions and Uses Thereof | TLN1, FLNA, NPM1 | GAA 775/4885L3MBTL1 435/4885 |
| US-20100303930-A1 | N-HALAMINE FORMULATIONS WITH ENHANCED ANTIMICROBIAL ACTIVITY | NHERF1, NIT2, NISCH | GAA 473/4885L3MBTL1 3678/4885 |
| US-20110200484-A1 | DISINFECTING, NONBLEACHING N-HALAMINE FOR USE WITH CONTACT LENS | NHERF1, HCN1, NPM1 | GAA 781/4885L3MBTL1 2357/4885 |
| US-10178866-B2 | N-halamine containing fibrous compositions and uses thereof | TLN1, FLNA, NPM1 | GAA 775/4885L3MBTL1 435/4885 |
| US-20230321314-A1 | N-HALAMINE CONTAINING FIBROUS COMPOSITIONS AND USES THEREOF | TLN1, FLNA, NPM1 | GAA 775/4885L3MBTL1 435/4885 |
| US-10981868-B1 | Single step regioselective cyclization and chlorination of hydroxyamino-N-(2-methylphenyl)acetamide to 5-chloro-7-methylindoline-2,3-dione | HAO2, HTR2C, HDHD5 | GAA 3702/4885L3MBTL1 4249/4885 |
| US-20190160199-A1 | N-HALAMINE CONTAINING FIBROUS COMPOSITIONS AND USES THEREOF | TLN1, FLNA, NPM1 | GAA 775/4885L3MBTL1 435/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.